An Interview with Crown Biosciences' SVP of Commercial, Alex Slater
Meet Alex Slater, Senior Vice President of Commercial at Crown Bioscience. With a career spanning three decades, Alex shares valuable insights on the monumental shifts and emerging trends in the CRO landscape, casting a vision for the future.
CROs: From Pair of Hands to Subject Matter Experts
One of the most critical changes Alex observed over his 30-year career in CROs is how customer needs and expectations have evolved from a pair of hands to subject matter experts. According to Alex, early CROs were perceived as essential facilitators, carrying out routine tasks for clients. Over time, however, a substantial increase in outsourcing led to CROs' explosive growth, transforming them into respected organizations renowned for their expertise.
Accelerating Growth and the Shift Toward Integrated Services
The rapid growth in the CRO industry was partly driven by evolving client needs, leading to significant consolidation within the industry. Today's industry giants reflect this trend, with many CROs tracing their heritage back to multiple smaller companies, each contributing their unique expertise.
Despite the accelerated shift towards consolidation, Alex notes that CROs are now broadening their scope, moving from niche expertise to a wider range of services. This transformation enhances CROs' ability to address their clients’ unique challenges and deliver bespoke solutions.
Local Presence Vs. Global Coverage: The Balancing Act
As CROs expand their global footprint, the question of local vs. global relevance comes into sharp focus. According to Alex, the answer is complex, with multiple factors at play such as ease of shipping test articles, cost, and the need for specific expertise. The ideal solution often involves a balance of local and global presence, allowing for flexibility and a tailored approach to individual client needs.
Overall, Alex's insightful interview provides a fascinating snapshot of the shifting CRO industry, emphasizing how these trends are shaping the future of drug discovery and development. As the CRO industry continues to evolve and adapt, it's clear that the role of a strategic partner will not be lessening in time soon.
